CLINICAL_TRIALS ClinicalTrials.gov record update

Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04467671
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:39.214249+00:00
Published At: 2025-06-27T00:00:00+00:00
Record Updated At: 2025-06-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HLH - Hypoplastic Left Heart Syndrome", "DORV", "DILV - Double Inlet Left Ventricle", "Mitral Atresia", "Tricuspid Atresia", "Unbalanced AV Canal", "Single-ventricle", "Heart Defects, Congenital", "Cardiovascular Abnormalities", "Cardiovascular Diseases", "Heart Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-06-27"
protocolSection.identificationModule.nctId: "NCT04467671"
protocolSection.identificationModule.officialTitle: "Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection."
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.